Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – As first-line therapy for advanced chronic lymphocytic leukemia, bendamustine produced significantly higher response rates and longer progression-free survival than chlorambucil in a phase…
As medical school debt goes up and reimbursement for family medicine, pediatrics and internal medicine remains on shaky ground, the primary-care field over the last decade has become…
NEW YORK (Reuters Health) – Both progression-free and overall survival are extended in patients with advanced non-small cell lung cancer treated with erlotinib following standard chemotherapy, according to…
NEW YORK (Reuters Health) – Due to hemoglobin degradation, delayed return of fecal occult blood tests (FOBTs) may miss colorectal adenomas and possibly also overt malignancy, according to…
NEW YORK (Reuters Health) – INR testing intervals of 4 weeks or less are typically recommended for patients on long-term warfarin therapy, but new research suggests that less…
Jeff Larche, owner of Digital Solid, a digital marketing consultancy and blog, shares the basics of social networking. A social network is an online community of people who…
Jeff Larche, owner of Digital Solid, a digital marketing consultancy and blog, talks about Search Engine Marketing (SEM) which is the process of improving the volume or quality…
NEW YORK (Reuters Health) – Allogeneic blood transfusions in patients who undergo coronary artery bypass graft surgery (CABG) substantially increase the patient’s odds of nosocomial infection, hospital readmission…
NEW YORK (Reuters Health) – Lung volume reduction surgery extends survival in patients with advanced emphysema and also improves quality of life, new research confirms. “We found lung…
NEW YORK (Reuters Health) – Patients hospitalized for acute coronary syndrome (ACS) are less likely to survive until discharge if they have a known history of prior atherosclerosis,…
